Shanghai Xinyi United Pharmaceutical

Shanghai Sine United Pharmaceutical is a prominent subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), specializing in the research, development, and manufacturing of a broad range of pharmaceutical products. The company operates under the historic Sine (Xinyi) brand, which has been a staple of the Chinese pharmaceutical market since 1916. Its extensive portfolio includes chemical drugs and traditional Chinese medicines (TCM) targeting therapeutic areas such as cardiovascular diseases, digestive disorders, and respiratory conditions. Sine United maintains multiple GMP-certified production facilities and is recognized for its expertise in various dosage forms, including oral solids and injections. As part of the SPH group, the company benefits from integrated R&D capabilities and a vast national distribution network, positioning it as a leader in China's healthcare sector. The company is also active in the development of generic medications and conducting bioequivalence studies to ensure high standards of efficacy and safety.